Citations

Showing 10 of 108083 citations.

Physicians Interrupting Patients
Phillips, Kari A. , Ospina, Naykky Singh , Phillips, Kari Ann, Singh Ospina, Naykky

Mayo Clinic

JAMA | July 3, 2017 | Volume: 318 | Issue: 1 | Pages: 93

10.1001/jama.2017.6493 | PMID 28672309 Get It

Feasibility Assessment of Microwave Ablation for Treating Esophageal Varices
Šebek, Jan , Curto, Sergio , Eaton-Evans, Jimmy, Bouchier-Hayes, Jonathan, Ruvio, Giuseppe , Ganta, Chanran, Beard, Warren L., Buttar, Navtej , Song, Louis Wong Kee, Prakash, Punit

Mayo Clinic

Journal of Medical Devices | July 3, 2017 | Volume: 11 | Issue: 3 | Pages: No page available

10.1115/1.4037187 Get It

Esophageal varices are a significant complication of portal hypertension. Endoscopic variceal ligation (EVL) is one of the clinical standards for treating these varices and preventing their hemorrhage. Limitations of EVL include the risk of stricture formation and postband ulcer bleeding due to the damage caused to the esophageal mucosa, as well as the need for multiple endoscopic treatment sessions to eradicate the varices. The goal of this study is to develop a device and evaluate the technical feasibility of microwave ablation to seal esophageal varices, while preventing thermal damage to the surface mucosal tissue. A microwave applicator with a directional radiation pattern was developed for endoscopic ablation of esophageal varices. Electromagnetic and bioheat transfer computational models were employed to optimize the design of the microwave applicator and evaluate energy delivery strategies for this application. Experiments in ex vivo and in vivo tissue were employed to verify simulation results. Simulations predicted enhanced heating performance of the antenna using an angled monopole radiating element. Further, simulations indicate that while the endoscopic cap attenuated electric fields in tissue, it also enhanced surface cooling of tissue, increasing the likelihood of preserving mucosal tissue. Experiments in ex vivo tissue indicated the feasibility of sealing veins with 77 W microwave power delivered for 30 s. In vivo experiments demonstrated the ability to seal veins, while preserving surface tissue. This study demonstrated the technical feasibility of microwave thermal ablation for treating esophageal varices using a 2.45 GHz water-cooled directional microwave applicator.
Repetition priming in mild cognitive impairment and mild dementia: Impact of educational attainment
O’Shea, Deirdre , Wit, Liselotte De , Yutsis, Maya, Castro, Melissa, Smith, Glenn E. , De Wit, Liselotte

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | July 3, 2017 | Volume: 40 | Issue: 4 | Pages: 338-346

10.1080/13803395.2017.1347253 | PMID 28671486 Get It

Alcoholic hepatitis: Continued drinking and the mourning after
Simonetto, Douglas A. , Kamath, Patrick S. , Shah, Vijay H. , Simonetto, Douglas A

Mayo Clinic

Hepatology | July 3, 2017 | Volume: 66 | Issue: 5 | Pages: 1370-1372

10.1002/hep.29349 | PMID 28671334 Get It

Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Barrdahl, Myrto , Hopper, John L. , Southey, Melissa C. , Fasching, Peter A. , Beckmann, Matthias W. , Gago-Domínguez, Manuela , Castelao, Jose E. , Guénel, Pascal , Truong, Thérèse , Bojesen, Stig E. , Gapstur, Susan M. , Gaudet, Mia M. , Brenner, Hermann , Brauch, Hiltrud , Hamann, Ute , Mannermaa, Arto, Lambrechts, Diether , Jongen, Lynn , Flesch‐Janys, Dieter, Thoene, Kathrin, Couch, Fergus J. , Simard, Jacques , Goldberg, Mark S. , Figueroa, Jonine D. , Michailidou, Kyriaki , Bolla, Manjeet K. , Wang, Qin , Eilber, Ursula, Swerdlow, Anthony J. , Schoemaker, Minouk J. , García‐Closas, Montserrat , Easton, Douglas F. , Chang‐Claude, Jenny , Durocher, Francine , Barrdahl, Myrto , Lambrechts, Diether , Rudolph, Anja , Fasching, Peter A , Barrdahl, Myrto , Rudolph, Anja , Broeks, Annegien , Arndt, Volker , Mannermaa, Arto, Couch, Fergus J. , Giles, Graham G. , Dennis, Joe , Behrens, Sabine , Czene, Kamila , Hall, Per N , Cox, Angela , Cross, Simon S. , Dunning, Alison M. , Kaaks, Rudolf , Pharoah, Paul D.P. , Schmidt, Marjanka K. , Milne, Roger L. , Lambrechts, Diether , Swerdlow, Anthony J , Southey, Melissa C , Lambrechts, Diether , Brenner, Hermann , Gago-Dominguez, Manuela , Guénel, Pascal , García-Closas, Montserrat , Michailidou, Kyriaki , Simard, Jacques , Figueroa, Jonine D , Bojesen, Stig E , Schoemaker, Minouk J , Truong, Therese , Brauch, Hiltrud

Mayo Clinic

International Journal of Cancer | July 3, 2017 | Volume: 141 | Issue: 9 | Pages: 1830-1840

10.1002/ijc.30859 | PMID 28670784 Get It

Investigating the most likely causal variants identified by fine‐mapping analyses may improve the power to detect gene–environment interactions. We assessed the interplay between 70 single nucleotide polymorphisms identified by genetic fine‐scale mapping of susceptibility loci and 11 epidemiological breast cancer risk factors in relation to breast cancer. Analyses were conducted on up to 58,573 subjects (26,968 cases and 31,605 controls) from the Breast Cancer Association Consortium, in one of the largest studies of its kind. Analyses were carried out separately for estrogen receptor (ER) positive (ER+) and ER negative (ER–) disease. The Bayesian False Discovery Probability (BFDP) was computed to assess the noteworthiness of the results. Four potential gene–environment interactions were identified as noteworthy (BFDP < 0.80) when assuming a true prior interaction probability of 0.01. The strongest interaction result in relation to overall breast cancer risk was found between CFLAR‐rs7558475 and current smoking (ORint = 0.77, 95% CI: 0.67–0.88, pint = 1.8 × 10−4). The interaction with the strongest statistical evidence was found between 5q14‐rs7707921 and alcohol consumption (ORint =1.36, 95% CI: 1.16–1.59, pint = 1.9 × 10−5) in relation to ER– disease risk. The remaining two gene–environment interactions were also identified in relation to ER– breast cancer risk and were found between 3p21‐rs6796502 and age at menarche (ORint = 1.26, 95% CI: 1.12–1.43, pint =1.8 × 10−4) and between 8q23‐rs13267382 and age at first full‐term pregnancy (ORint = 0.89, 95% CI: 0.83–0.95, pint = 5.2 × 10−4). While these results do not suggest any strong gene–environment interactions, our results may still be useful to inform experimental studies. These may in turn, shed light on the potential interactions observed.
Intra‐articular injection of a substance P inhibitor affects gene expression in a joint contracture model
Lewallen, Eric A. , An, Kai‐Nan, Grill, Diane E. , Steinmann, Scott P. , Yao, Jie , Salib, Christopher G. , Trousdale, William H. , Reina, Nicolas , Kremers, Hilal Maradit , Lewallen, David G. , Wijnen, André J. van , Sanchez-Sotelo, Joaquin, Yao, Jie J, Kremers, Hilal M, van Wijnen, Andre J , Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , An, Kai‐Nan , Abdel, Matthew P. , Maradit Kremers, Hilal

Mayo Clinic

Journal of Cellular Biochemistry | July 3, 2017 | Volume: 119 | Issue: 2 | Pages: 1326-1336

10.1002/jcb.26256 | PMID 28671282 Get It

AbstractSubstance P (SP), a neurotransmitter released after injury, has been linked to deregulated tissue repair and fibrosis in musculoskeletal tissues and other organs. Although SP inhibition is an effective treatment for nausea, it has not been previously considered as an anti‐fibrotic therapy. Although there are extensive medical records of individuals who have used SP antagonists, our analysis of human registry data revealed that patients receiving these antagonists and arthroplasty are exceedingly rare, thus precluding a clinical evaluation of their potential effects in the context of arthrofibrosis. Therefore, we pursued in vivo studies to assess the effect of SP inhibition early after injury on pro‐fibrotic gene expression and contractures in an animal model of post‐traumatic joint stiffening. Skeletally mature rabbits (n = 24) underwent surgically induced severe joint contracture, while injected with either fosaprepitant (a selective SP antagonist) or saline (control) early after surgery (3, 6, 12, and 24 h). Biomechanical testing revealed that differences in mean contracture angles between the groups were not statistically significant (P = 0.27), suggesting that the drug neither mitigates nor exacerbates joint contracture. However, microarray gene expression analysis revealed that mRNA levels for proteins related to cell signaling, pro‐angiogenic, pro‐inflammatory, and collagen matrix production were significantly different between control and fosaprepitant treated rabbits (P < 0.05). Hence, our study demonstrates that inhibition of SP alters expression of pro‐fibrotic genes in vivo. This finding will motivate future studies to optimize interventions that target SP to reduce the formation of post‐traumatic joint contractures.
Reply re: “Profile of cognitive impairment and underlying pathology in multiple system atrophy”
Koga, Shunsuke , Parks, Adam , Dickson, Dennis W. , Koga, Shunsuke

Mayo Clinic

Movement Disorders | July 3, 2017 | Volume: 32 | Issue: 9 | Pages: 1339-1340

10.1002/mds.27084 | PMID 28671292 Get It

Evoked otoacoustic emissions in differential diagnosis: A case report
Robinette, Martin S., Facer, George W.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | July 3, 2017 | Volume: 105 | Issue: 1 | Pages: 120-123

10.1177/019459989110500119 | PMID 1908994 Get It

CREATION AND USE OF A NATIONAL, COMPETENCY BASED GERIATRICS EDUCATION CURRICULUM: WEBGEMS
Shah, Ashfaque Ahmad , Usiak, Craig, Sauvigné, Karen, Leipzig, Rosanne M. , Marshall, N. , Callahan, Kathryn E. , Howe, Carol

Mayo Clinic

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 206-206

10.1093/geroni/igx004.778 Get It

ASSOCIATION OF ADIPOSITY, TELOMERE LENGTH AND AGE: NHANES 1999–2002
MacKenzie, Todd A. , Rippberger, P., Bartels, Stephen J. , Batsis, John A. , Vásquez, Elizabeth , Germain, Cassandra , Emeny, Rebecca T. , López-Jiménez, Francisco

Mayo Clinic

Innovation in Aging | July 1, 2017 | Volume: 1 | Issue: suppl_1 | Pages: 217-218

10.1093/geroni/igx004.816 Get It